The Size of the Middle East & Africa Gene Expression Analysis Market is valued at USD 0.40 Billion in 2022 and is expected to reach USD 0.57 billion by 2027, to grow at a CAGR of 7.53% during the forecast period 2022 to 2027.
The market's growth is being driven by the growing demand for effective cancer treatments, the falling cost of sequencing procedures, and the increasing inclination of patients to personalized drugs. According to the WHO, in 2019, MEA accounts for 5.4% of all cancer cases and 2.3% of cancer deaths, although it has only 5% of the world's population. These numbers require advanced treatments through the use of gene expression analysis.
According to the National Institute of Cancer Health, in 2019, approximately 1,755,000 new cancer cases were diagnosed, and about 619,000 people died from the disease. Despite this, in 2018, there were approximately 55.5 million cancer survivors, and this figure is expected to increase to 60.3 million by 2027, which can be resolved through scientific advancements in gene expressions analysis.
With the increasing availability and falling costs of DNA technologies, gene expression has become indispensable for drug discovery and development. Increasing prevalence of chronic diseases and the associated demand for advanced healthcare offer lucrative opportunities for market MEA gene expression analysis.
In addition, the development of personalized medicines to treat these ailments has made it possible to modify the diagnosis and treatment methods according to the patient's individual needs. In addition, the increased use of gene expression analysis data for various applications, such as diagnostics, toxicology, and pharmacogenomics, will further increase the market size until 2028. In addition, the development of genomic data and rising government funding is driving the market's growth.
However, the lack of skilled labor and the high cost of the instruments may hamper the market's growth during the evaluation period.
This research report on the Middle East & Africa Gene Expression Analysis Market has been segmented and sub-segmented into the following categories
Geographically, the Middle East accounted for 45% of the MEA gene expression analysis market share in 2020 and is expected to gain ground through 2028. Regional industry growth is driven by increased demand for gene therapy, supportive government initiatives, emphasis on gene expression studies, and funding for NGS research.
The UAE gene expression analysis market is expected to generate a 3.1% CAGR through 2028 due to rapid economic developments and the growing demand for better healthcare solutions in the region. Saudi Arabia is investing heavily in recombinant DNA technology and genetic engineering, which positively impacts the growth of the gene expression industry. In addition, increased public spending on cancer research and related programs will drive the size of the market for years to come.
Qatar will have good growth due to increasing research activity and the growing popularity of gene expression testing. In addition, the well-developed healthcare industry is expected to boost the gene expression analysis market.
Africa gene expression analysis market is expected to have a reasonable market growth rate region due to increased government investment in genomics and continuously developing economies. In addition, factors such as the growth of public primary and secondary care facilities have increased in recent years and have kept pace with rapid urbanization. Hence, these factors are encouraging market growth in this region. In contrast, few areas in Africa will have the lowest market share.
KEY MARKET PLAYERS
Key Market Companies dominating the Middle East & Africa Gene Expression Analysis Market Profiled in the Report are PerkinElmer, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, GE Healthcare, QIAGEN N.V., Affymetrix, Life Technologies, Agilent Technologies, Roche, Illumina, Inc., Oxford Gene Technology, and Luminex Corporation.,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org